IL1A and cancer: IL-1 system ligands and receptors are recognized as key players involved in any condition associated with inflammation and innate or adaptive immune responses, ranging from host responses in infections and sterile tissue damage and inflammation to dysmetabolism, cardiovascular diseases, neurodegeneration and cancer.